US IPO Weekly Recap: The Second Quarter Starts With No IPOs

424
30
Favorite

US IPO Weekly Recap: The Second Quarter Starts With No IPOs

Renaissance Capital2022-04-09

There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

424

Report

Comment（30）

estherytwu
·2022-04-10
Ok
Reply
1
Report
Jerryoic
·2022-04-09
Yes
Reply
5
Report
ToTheM00N
·2022-04-09
Ok
Reply
5
Report
SCLIEW
·2022-04-09
666
Reply
5
Report
ycheong
·2022-04-09
like
Reply
4
Report
hohok
·2022-04-09
Like
Reply
5
Report
FT585
·2022-04-09
Like
Reply
2
Report
DrSam
·2022-04-09
No IPO is a poor sign for the market
Reply
1
Report
HENRYCSC
·2022-04-09
Like pls
Reply
2
Report
Jameslim29
·2022-04-09
Ok
Reply
2
Report
Mib1515
·2022-04-09
Ok
Reply
3
Report
kevinlaisq
·2022-04-09
Pls like
Reply
3
Report
YJ Lee
·2022-04-09
Ok
Reply
3
Report
OddEyeCircle
·2022-04-09
IPO to the soil
Reply
2
Report
Singman
·2022-04-09
Like
Reply
3
Report
onglaihuat
·2022-04-09
G
Reply
3
Report
Jeremysee
·2022-04-09
I think is expected??
Reply
5
Report
Venus888
·2022-04-09
Pls like. Thanks
Reply
5
Report
El_Nino
·2022-04-09
K la
Reply
3
Report
vaicrazy
·2022-04-09
Ok
Reply
3
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1190868678?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-04-09 07:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190868678","market":"us","top_or_hot":-1,"title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","media":"Renaissance Capital","content":"<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Source Link</a>\n\n</div>\n","source":"lsy1603787993745","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DECAU","symbol_name":"Denali Capital Acquisition Corp","start_time":0,"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","article_id":"1190868678","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","pubTimestamp":1649462070,"sourceInfo":{"source_id":"lsy1603787993745","name":"Renaissance Capital"},"weMediaInfo":null,"summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","collect":0,"end_time":0,"defaultTopTitle":"renaissancecapital.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"translate_title":"美国首次公开募股周报：第二季度无首次公开募股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DECAU":0.9},"content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9015792162,"gmtCreate":1649552816722,"gmtModify":1676534528286,"author":{"id":"3580294349597017","authorId":"3580294349597017","name":"estherytwu","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3580294349597017","idStr":"3580294349597017"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015792162","repostId":1190868678,"repostType":4,"repost":{"id":"1190868678","kind":"news","pubTimestamp":1649462070,"share":"https://ttm.financial/m/news/1190868678?lang=&edition=fundamental","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9015532439,"gmtCreate":1649507705666,"gmtModify":1676534523102,"author":{"id":"3566964893686628","authorId":"3566964893686628","name":"Jerryoic","avatar":"https://static.tigerbbs.com/cdddd03a99beddec060abfd42dde0207","vip":1,"hat":"https://static.tigerbbs.com/7b75ce0c34afff716602792a5d0929dd","crmLevel":5,"crmLevelSwitch":1,"authorIdStr":"3566964893686628","idStr":"3566964893686628"},"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015532439","repostId":1190868678,"repostType":2,"repost":{"id":"1190868678","kind":"news","pubTimestamp":1649462070,"share":"https://ttm.financial/m/news/1190868678?lang=&edition=fundamental","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9015216242,"gmtCreate":1649485206390,"gmtModify":1676534520353,"author":{"id":"3581730511233431","authorId":"3581730511233431","name":"ToTheM00N","avatar":"https://static.tigerbbs.com/7b77b689650adddd8a8560dc89fcb930","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3581730511233431","idStr":"3581730511233431"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015216242","repostId":1190868678,"repostType":4,"repost":{"id":"1190868678","kind":"news","pubTimestamp":1649462070,"share":"https://ttm.financial/m/news/1190868678?lang=&edition=fundamental","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9015673664,"gmtCreate":1649478041479,"gmtModify":1676534519389,"author":{"id":"4092970777728640","authorId":"4092970777728640","name":"SCLIEW","avatar":"https://static.tigerbbs.com/5da553e4d3d35db75d1caae023ca8a03","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4092970777728640","idStr":"4092970777728640"},"htmlText":"666","listText":"666","text":"666","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015673664","repostId":1190868678,"repostType":4,"repost":{"id":"1190868678","kind":"news","pubTimestamp":1649462070,"share":"https://ttm.financial/m/news/1190868678?lang=&edition=fundamental","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9015663791,"gmtCreate":1649473514515,"gmtModify":1676534518391,"author":{"id":"4101515922371630","authorId":"4101515922371630","name":"ycheong","avatar":"https://static.tigerbbs.com/e72f54521a5b0b85fdb76102b268baa3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4101515922371630","idStr":"4101515922371630"},"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015663791","repostId":1190868678,"repostType":4,"repost":{"id":"1190868678","kind":"news","pubTimestamp":1649462070,"share":"https://ttm.financial/m/news/1190868678?lang=&edition=fundamental","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9015613942,"gmtCreate":1649471238595,"gmtModify":1676534517873,"author":{"id":"3581844295426037","authorId":"3581844295426037","name":"hohok","avatar":"https://static.tigerbbs.com/b9ae72338572431c58f911b40ae0f930","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581844295426037","idStr":"3581844295426037"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015613942","repostId":1190868678,"repostType":4,"repost":{"id":"1190868678","kind":"news","pubTimestamp":1649462070,"share":"https://ttm.financial/m/news/1190868678?lang=&edition=fundamental","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9015619759,"gmtCreate":1649471224940,"gmtModify":1676534517875,"author":{"id":"3562726241279787","authorId":"3562726241279787","name":"FT585","avatar":"https://static.tigerbbs.com/734b50619b12425294cb4715814bdedb","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3562726241279787","idStr":"3562726241279787"},"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015619759","repostId":1190868678,"repostType":4,"repost":{"id":"1190868678","kind":"news","pubTimestamp":1649462070,"share":"https://ttm.financial/m/news/1190868678?lang=&edition=fundamental","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9015691700,"gmtCreate":1649469100295,"gmtModify":1676534517396,"author":{"id":"3582967351944758","authorId":"3582967351944758","name":"DrSam","avatar":"https://static.tigerbbs.com/2161cecb6376985512402ff4b6052ccc","vip":1,"crmLevel":4,"crmLevelSwitch":1,"authorIdStr":"3582967351944758","idStr":"3582967351944758"},"htmlText":"No IPO is a poor sign for the market&nbsp;","listText":"No IPO is a poor sign for the market&nbsp;","text":"No IPO is a poor sign for the market","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015691700","repostId":1190868678,"repostType":4,"repost":{"id":"1190868678","kind":"news","pubTimestamp":1649462070,"share":"https://ttm.financial/m/news/1190868678?lang=&edition=fundamental","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9015604737,"gmtCreate":1649468718444,"gmtModify":1676534517289,"author":{"id":"3575091428590185","authorId":"3575091428590185","name":"HENRYCSC","avatar":"https://static.tigerbbs.com/6d47a6dec25b21dc547a5b982674c499","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3575091428590185","idStr":"3575091428590185"},"htmlText":"Like pls&nbsp;","listText":"Like pls&nbsp;","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015604737","repostId":1190868678,"repostType":4,"repost":{"id":"1190868678","kind":"news","pubTimestamp":1649462070,"share":"https://ttm.financial/m/news/1190868678?lang=&edition=fundamental","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9015873150,"gmtCreate":1649467516506,"gmtModify":1676534516744,"author":{"id":"3563070726162010","authorId":"3563070726162010","name":"Jameslim29","avatar":"https://static.tigerbbs.com/753b3384fa57ecc8b7314cedcb5ed66e","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3563070726162010","idStr":"3563070726162010"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015873150","repostId":1190868678,"repostType":4,"repost":{"id":"1190868678","kind":"news","pubTimestamp":1649462070,"share":"https://ttm.financial/m/news/1190868678?lang=&edition=fundamental","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9015870337,"gmtCreate":1649467331688,"gmtModify":1676534516696,"author":{"id":"3579210010472476","authorId":"3579210010472476","name":"Mib1515","avatar":"https://static.tigerbbs.com/c0b85730abdbda4c69ac70cb9d1f58cb","vip":1,"crmLevel":5,"crmLevelSwitch":1,"authorIdStr":"3579210010472476","idStr":"3579210010472476"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015870337","repostId":1190868678,"repostType":4,"repost":{"id":"1190868678","kind":"news","pubTimestamp":1649462070,"share":"https://ttm.financial/m/news/1190868678?lang=&edition=fundamental","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9015843119,"gmtCreate":1649466754543,"gmtModify":1676534516524,"author":{"id":"3572874548548490","authorId":"3572874548548490","name":"kevinlaisq","avatar":"https://static.tigerbbs.com/329de1199f764a89b7cadf50308e183d","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3572874548548490","idStr":"3572874548548490"},"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015843119","repostId":1190868678,"repostType":4,"repost":{"id":"1190868678","kind":"news","pubTimestamp":1649462070,"share":"https://ttm.financial/m/news/1190868678?lang=&edition=fundamental","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9015858818,"gmtCreate":1649466145652,"gmtModify":1676534516337,"author":{"id":"4108816210230400","authorId":"4108816210230400","name":"YJ Lee","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"4108816210230400","idStr":"4108816210230400"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015858818","repostId":1190868678,"repostType":4,"repost":{"id":"1190868678","kind":"news","pubTimestamp":1649462070,"share":"https://ttm.financial/m/news/1190868678?lang=&edition=fundamental","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9015850667,"gmtCreate":1649465845168,"gmtModify":1676534516258,"author":{"id":"3582065904370135","authorId":"3582065904370135","name":"OddEyeCircle","avatar":"https://static.tigerbbs.com/bd89742cea79ac97ec7da1a7bdbc2a14","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3582065904370135","idStr":"3582065904370135"},"htmlText":"IPO to the soil","listText":"IPO to the soil","text":"IPO to the soil","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015850667","repostId":1190868678,"repostType":4,"repost":{"id":"1190868678","kind":"news","pubTimestamp":1649462070,"share":"https://ttm.financial/m/news/1190868678?lang=&edition=fundamental","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9015829023,"gmtCreate":1649465274747,"gmtModify":1676534515964,"author":{"id":"3575125836760247","authorId":"3575125836760247","name":"Singman","avatar":"https://static.tigerbbs.com/d770feb757705f2d631d2d5f381ae07b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3575125836760247","idStr":"3575125836760247"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015829023","repostId":1190868678,"repostType":4,"repost":{"id":"1190868678","kind":"news","pubTimestamp":1649462070,"share":"https://ttm.financial/m/news/1190868678?lang=&edition=fundamental","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9015862072,"gmtCreate":1649464977446,"gmtModify":1676534515843,"author":{"id":"3585648549833646","authorId":"3585648549833646","name":"onglaihuat","avatar":"https://static.tigerbbs.com/8beed4d730329353a71b58a536060ca8","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3585648549833646","idStr":"3585648549833646"},"htmlText":"G","listText":"G","text":"G","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015862072","repostId":1190868678,"repostType":4,"repost":{"id":"1190868678","kind":"news","pubTimestamp":1649462070,"share":"https://ttm.financial/m/news/1190868678?lang=&edition=fundamental","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9015881558,"gmtCreate":1649464168351,"gmtModify":1676534515597,"author":{"id":"4089499026613770","authorId":"4089499026613770","name":"Jeremysee","avatar":"https://static.itradeup.com/news/110f1753ebe99c114721ba94b7030c57","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"4089499026613770","idStr":"4089499026613770"},"htmlText":"I think is expected??","listText":"I think is expected??","text":"I think is expected??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015881558","repostId":1190868678,"repostType":2,"repost":{"id":"1190868678","kind":"news","pubTimestamp":1649462070,"share":"https://ttm.financial/m/news/1190868678?lang=&edition=fundamental","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9015816575,"gmtCreate":1649463521385,"gmtModify":1676534515362,"author":{"id":"3572313172431959","authorId":"3572313172431959","name":"Venus888","avatar":"https://static.tigerbbs.com/2eb10c539f367e4d8f1ae8ddf081bfdf","vip":1,"crmLevel":9,"crmLevelSwitch":0,"authorIdStr":"3572313172431959","idStr":"3572313172431959"},"htmlText":"Pls like. Thanks","listText":"Pls like. Thanks","text":"Pls like. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015816575","repostId":1190868678,"repostType":4,"repost":{"id":"1190868678","kind":"news","pubTimestamp":1649462070,"share":"https://ttm.financial/m/news/1190868678?lang=&edition=fundamental","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9015816962,"gmtCreate":1649463472196,"gmtModify":1676534515338,"author":{"id":"3579591519090572","authorId":"3579591519090572","name":"El_Nino","avatar":"https://static.tigerbbs.com/6b1b731af69caf76640812930188d9d2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3579591519090572","idStr":"3579591519090572"},"htmlText":"K la","listText":"K la","text":"K la","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015816962","repostId":1190868678,"repostType":2,"repost":{"id":"1190868678","kind":"news","pubTimestamp":1649462070,"share":"https://ttm.financial/m/news/1190868678?lang=&edition=fundamental","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9015811112,"gmtCreate":1649463366205,"gmtModify":1676534515299,"author":{"id":"3573989963279471","authorId":"3573989963279471","name":"vaicrazy","avatar":"https://static.tigerbbs.com/5e1fe01bd5dda3f3a00e7197697a8873","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3573989963279471","idStr":"3573989963279471"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9015811112","repostId":1190868678,"repostType":4,"repost":{"id":"1190868678","kind":"news","pubTimestamp":1649462070,"share":"https://ttm.financial/m/news/1190868678?lang=&edition=fundamental","pubTime":"2022-04-09 07:54","market":"us","language":"en","title":"US IPO Weekly Recap: The Second Quarter Starts With No IPOs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868678","media":"Renaissance Capital","summary":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial f","content":"<html><head></head><body><p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.</p><p>The week’s sole deal was <b>Denali Capital Acquisition</b>(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.</p><p>Three IPOs submitted initial filings. Norovirus vaccine developer <b>HilleVax</b>(HLVX) filed to raise $100 million. Eye disease biotech <b>Belite Bio</b>(BLTE) filed to raise $46 million, inflammatory disease biotech <b>Intrinsic Medicine</b>(INRX) filed to raise $29 million, and projection screen maker <b>Strong Global Entertainment</b>(SGE) filed to raise $16 million.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: The Second Quarter Starts With No IPOs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: The Second Quarter Starts With No IPOs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-09 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DECAU":"Denali Capital Acquisition Corp"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91947/US-IPO-Weekly-Recap-The-second-quarter-starts-with-no-IPOs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190868678","content_text":"There were no IPOs in the first week of April, though one SPAC priced. Four IPOs submitted initial filings.The week’s sole deal was Denali Capital Acquisition(DECAU), which raised $75 million. Led by the CEO of US Tiger Securities, the SPAC plans to target the technology, hospitality, or consumer services sectors.Three IPOs submitted initial filings. Norovirus vaccine developer HilleVax(HLVX) filed to raise $100 million. Eye disease biotech Belite Bio(BLTE) filed to raise $46 million, inflammatory disease biotech Intrinsic Medicine(INRX) filed to raise $29 million, and projection screen maker Strong Global Entertainment(SGE) filed to raise $16 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":424,"commentSize":30,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}